Johnson & Johnson intends to exit the drug-coated stent market by the end of this year-which could be good news for rivals like Fridley-based Medtronic, Inc., and Natick, Massachusetts-based Boston ...
NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.
NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results